APO Research

APO RESEARCH · REPORT

Biomedical CRO

Selected research

Market Structure

Global Biomedical CRO Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Biomedical CRO market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Biomedical CRO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Biomedical CRO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biomedical CRO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Biomedical CRO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Biomedical CRO include Charles River, Wuxi AppTec, Labcorp, Eurofins Scientific, PPD, ICON Plc, Pharmaron, Inotiv and ChemPartner, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Biomedical CRO market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Biomedical CRO and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Biomedical CRO revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Biomedical CRO market size, projected growth trends, production technologies, key applications, and end-use industries.

Biomedical CRO Segment by Company

Charles River

Wuxi AppTec

Labcorp

Eurofins Scientific

PPD

ICON Plc

Pharmaron

Inotiv

ChemPartner

JOINN Lab

EVOTEC

Medicilon

Crown Bioscience

Champion Oncology

Biomedical CRO Segment by Type

Preclinical CRO

Clinical CRO

Biomedical CRO Segment by Application

Biological Industry

Medical Industry

Biomedical CRO Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biomedical CRO market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biomedical CRO and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biomedical CRO.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Biomedical CRO in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biomedical CRO industry.

Chapter 3: Detailed analysis of Biomedical CRO companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biomedical CROrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Biomedical CRO Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Preclinical CRO Table 3. Key Players of Clinical CRO Table 4. Global Biomedical CRO Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Biological Industry Table 6. Key Players of Medical Industry Table 7. Global Biomedical CRO Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global Biomedical CRO Market Size by Region (2021-2026) & (US$ Million) Table 9. Global Biomedical CRO Market Share by Region (2021-2026) Table 10. Global Biomedical CRO Market Size by Region (2027-2032) & (US$ Million) Table 11. Global Biomedical CRO Market Share by Region (2027-2032) Table 12. Biomedical CRO Industry Trends Table 13. Biomedical CRO Industry Drivers Table 14. Biomedical CRO Industry Opportunities and Challenges Table 15. Biomedical CRO Industry Restraints Table 16. Global Biomedical CRO Revenue by Company (US$ Million) & (2021-2026) Table 17. Global Biomedical CRO Revenue Market Share by Company (2021-2026) Table 18. Global Biomedical CRO Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global Biomedical CRO Key Company Head Office and Area Served Table 20. Global Biomedical CRO Company, Product Type & Application Table 21. Global Biomedical CRO Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global Biomedical CRO by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global Biomedical CRO Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Biomedical CRO Market Size by Type (2021-2026) & (US$ Million) Table 26. Global Biomedical CRO Market Size by Type (2027-2032) & (US$ Million) Table 27. Global Biomedical CRO Revenue Market Share by Type (2021-2026) Table 28. Global Biomedical CRO Revenue Market Share by Type (2027-2032) Table 29. Global Biomedical CRO Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Biomedical CRO Market Size by Application (2021-2026) & (US$ Million) Table 31. Global Biomedical CRO Market Size by Application (2027-2032) & (US$ Million) Table 32. Global Biomedical CRO Revenue Market Share by Application (2021-2026) Table 33. Global Biomedical CRO Revenue Market Share by Application (2027-2032) Table 34. Charles River Company Information Table 35. Charles River Business Overview Table 36. Charles River Biomedical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Charles River Biomedical CRO Product Portfolio Table 38. Charles River Recent Development Table 39. Wuxi AppTec Company Information Table 40. Wuxi AppTec Business Overview Table 41. Wuxi AppTec Biomedical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Wuxi AppTec Biomedical CRO Product Portfolio Table 43. Wuxi AppTec Recent Development Table 44. Labcorp Company Information Table 45. Labcorp Business Overview Table 46. Labcorp Biomedical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Labcorp Biomedical CRO Product Portfolio Table 48. Labcorp Recent Development Table 49. Eurofins Scientific Company Information Table 50. Eurofins Scientific Business Overview Table 51. Eurofins Scientific Biomedical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Eurofins Scientific Biomedical CRO Product Portfolio Table 53. Eurofins Scientific Recent Development Table 54. PPD Company Information Table 55. PPD Business Overview Table 56. PPD Biomedical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. PPD Biomedical CRO Product Portfolio Table 58. PPD Recent Development Table 59. ICON Plc Company Information Table 60. ICON Plc Business Overview Table 61. ICON Plc Biomedical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. ICON Plc Biomedical CRO Product Portfolio Table 63. ICON Plc Recent Development Table 64. Pharmaron Company Information Table 65. Pharmaron Business Overview Table 66. Pharmaron Biomedical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Pharmaron Biomedical CRO Product Portfolio Table 68. Pharmaron Recent Development Table 69. Inotiv Company Information Table 70. Inotiv Business Overview Table 71. Inotiv Biomedical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Inotiv Biomedical CRO Product Portfolio Table 73. Inotiv Recent Development Table 74. ChemPartner Company Information Table 75. ChemPartner Business Overview Table 76. ChemPartner Biomedical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. ChemPartner Biomedical CRO Product Portfolio Table 78. ChemPartner Recent Development Table 79. JOINN Lab Company Information Table 80. JOINN Lab Business Overview Table 81. JOINN Lab Biomedical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. JOINN Lab Biomedical CRO Product Portfolio Table 83. JOINN Lab Recent Development Table 84. EVOTEC Company Information Table 85. EVOTEC Business Overview Table 86. EVOTEC Biomedical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. EVOTEC Biomedical CRO Product Portfolio Table 88. EVOTEC Recent Development Table 89. Medicilon Company Information Table 90. Medicilon Business Overview Table 91. Medicilon Biomedical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 92. Medicilon Biomedical CRO Product Portfolio Table 93. Medicilon Recent Development Table 94. Crown Bioscience Company Information Table 95. Crown Bioscience Business Overview Table 96. Crown Bioscience Biomedical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 97. Crown Bioscience Biomedical CRO Product Portfolio Table 98. Crown Bioscience Recent Development Table 99. Champion Oncology Company Information Table 100. Champion Oncology Business Overview Table 101. Champion Oncology Biomedical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 102. Champion Oncology Biomedical CRO Product Portfolio Table 103. Champion Oncology Recent Development Table 104. North America Biomedical CRO Market Size by Type (2021-2026) & (US$ Million) Table 105. North America Biomedical CRO Market Size by Type (2027-2032) & (US$ Million) Table 106. North America Biomedical CRO Market Size by Application (2021-2026) & (US$ Million) Table 107. North America Biomedical CRO Market Size by Application (2027-2032) & (US$ Million) Table 108. North America Biomedical CRO Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 109. North America Biomedical CRO Market Size by Country (2021-2026) Table 110. North America Biomedical CRO Market Size by Country (2027-2032) Table 111. Europe Biomedical CRO Market Size by Type (2021-2026) & (US$ Million) Table 112. Europe Biomedical CRO Market Size by Type (2027-2032) & (US$ Million) Table 113. Europe Biomedical CRO Market Size by Application (2021-2026) & (US$ Million) Table 114. Europe Biomedical CRO Market Size by Application (2027-2032) & (US$ Million) Table 115. Europe Biomedical CRO Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. Europe Biomedical CRO Market Size by Country (2021-2026) Table 117. Europe Biomedical CRO Market Size by Country (2027-2032) Table 118. China Biomedical CRO Market Size by Type (2021-2026) & (US$ Million) Table 119. China Biomedical CRO Market Size by Type (2027-2032) & (US$ Million) Table 120. China Biomedical CRO Market Size by Application (2021-2026) & (US$ Million) Table 121. China Biomedical CRO Market Size by Application (2027-2032) & (US$ Million) Table 122. Asia Biomedical CRO Market Size by Type (2021-2026) & (US$ Million) Table 123. Asia Biomedical CRO Market Size by Type (2027-2032) & (US$ Million) Table 124. Asia Biomedical CRO Market Size by Application (2021-2026) & (US$ Million) Table 125. Asia Biomedical CRO Market Size by Application (2027-2032) & (US$ Million) Table 126. Asia Biomedical CRO Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 127. Asia Biomedical CRO Market Size by Country (2021-2026) Table 128. Asia Biomedical CRO Market Size by Country (2027-2032) Table 129. South America, Middle East & Africa Biomedical CRO Market Size by Type (2021-2026) & (US$ Million) Table 130. South America, Middle East & Africa Biomedical CRO Market Size by Type (2027-2032) & (US$ Million) Table 131. South America, Middle East & Africa Biomedical CRO Market Size by Application (2021-2026) & (US$ Million) Table 132. South America, Middle East & Africa Biomedical CRO Market Size by Application (2027-2032) & (US$ Million) Table 133. South America, Middle East & Africa Biomedical CRO Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 134. South America, Middle East & Africa Biomedical CRO Market Size by Country (2021-2026) Table 135. South America, Middle East & Africa Biomedical CRO Market Size by Country (2027-2032) Table 136. Research Programs/Design for This Report Table 137. Authors List of This Report Table 138. Secondary Sources Table 139. Primary Sources List of Figures Figure 1. Biomedical CRO Product Image Figure 2. Global Biomedical CRO Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Biomedical CRO Market Share by Type: 2025 VS 2032 Figure 4. Preclinical CRO Image Figure 5. Clinical CRO Image Figure 6. Global Biomedical CRO Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Biomedical CRO Market Share by Application: 2025 VS 2032 Figure 8. Biological Industry Image Figure 9. Medical Industry Image Figure 10. Global Biomedical CRO Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Biomedical CRO Market Size (2021-2032) & (US$ Million) Figure 12. Global Biomedical CRO Market Share by Region: 2025 VS 2032 Figure 13. Years Considered Figure 14. Global Biomedical CRO Market Share by Players in 2025 Figure 15. Global Top 5 and 10 Biomedical CRO Players Market Share by Revenue in 2025 Figure 16. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Biomedical CRO Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Biomedical CRO Revenue Market Share by Type (2021-2032) Figure 19. Global Biomedical CRO Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Biomedical CRO Revenue Market Share by Application (2021-2032) Figure 21. North America Biomedical CRO Market Size (2021-2032) & (US$ Million) Figure 22. North America Biomedical CRO Market Share by Type (2021-2032) Figure 23. North America Biomedical CRO Market Share by Application (2021-2032) Figure 24. North America Biomedical CRO Market Share by Country (2021-2032) Figure 25. United States Biomedical CRO Market Size (2021-2032) & (US$ Million) Figure 26. Canada Biomedical CRO Market Size (2021-2032) & (US$ Million) Figure 27. Mexico Biomedical CRO Market Size (2021-2032) & (US$ Million) Figure 28. Europe Biomedical CRO Market Size (2021-2032) & (US$ Million) Figure 29. Europe Biomedical CRO Market Share by Type (2021-2032) Figure 30. Europe Biomedical CRO Market Share by Application (2021-2032) Figure 31. Europe Biomedical CRO Market Share by Country (2021-2032) Figure 32. Germany Biomedical CRO Market Size (2021-2032) & (US$ Million) Figure 33. France Biomedical CRO Market Size (2021-2032) & (US$ Million) Figure 34. U.K. Biomedical CRO Market Size (2021-2032) & (US$ Million) Figure 35. Italy Biomedical CRO Market Size (2021-2032) & (US$ Million) Figure 36. Russia Biomedical CRO Market Size (2021-2032) & (US$ Million) Figure 37. Nordic Countries Biomedical CRO Market Size (2021-2032) & (US$ Million) Figure 38. China Biomedical CRO Market Size (2021-2032) & (US$ Million) Figure 39. China Biomedical CRO Market Share by Type (2021-2032) Figure 40. China Biomedical CRO Market Share by Application (2021-2032) Figure 41. Asia Biomedical CRO Market Size (2021-2032) & (US$ Million) Figure 42. Asia Biomedical CRO Market Share by Type (2021-2032) Figure 43. Asia Biomedical CRO Market Share by Application (2021-2032) Figure 44. Asia Biomedical CRO Market Share by Country (2021-2032) Figure 45. Japan Biomedical CRO Market Size (2021-2032) & (US$ Million) Figure 46. South Korea Biomedical CRO Market Size (2021-2032) & (US$ Million) Figure 47. Taiwan Biomedical CRO Market Size (2021-2032) & (US$ Million) Figure 48. Southeast Asia Biomedical CRO Market Size (2021-2032) & (US$ Million) Figure 49. India Biomedical CRO Market Size (2021-2032) & (US$ Million) Figure 50. Australia Biomedical CRO Market Size (2021-2032) & (US$ Million) Figure 51. South America, Middle East & Africa Biomedical CRO Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Biomedical CRO Market Share by Type (2021-2032) Figure 53. South America, Middle East & Africa Biomedical CRO Market Share by Application (2021-2032) Figure 54. South America, Middle East & Africa Biomedical CRO Market Share by Country (2021-2032) Figure 55. Brazil Biomedical CRO Market Size (2021-2032) & (US$ Million) Figure 56. South Africa Biomedical CRO Market Size (2021-2032) & (US$ Million) Figure 57. Saudi Arabia Biomedical CRO Market Size (2021-2032) & (US$ Million) Figure 58. Turkey Biomedical CRO Market Size (2021-2032) & (US$ Million) Figure 59. Argentina Biomedical CRO Market Size (2021-2032) & (US$ Million) Figure 60. UAE Biomedical CRO Market Size (2021-2032) & (US$ Million) Figure 61. Egypt Biomedical CRO Market Size (2021-2032) & (US$ Million) Figure 62. Chile Biomedical CRO Market Size (2021-2032) & (US$ Million) Figure 63. Research Process Figure 64. Key Executives Interviewed

Scope & coverage.

Types
  • Preclinical CRO
  • Clinical CRO
Applications
  • Biological Industry
  • Medical Industry
Companies covered
  • Charles River
  • Wuxi AppTec
  • Labcorp
  • Eurofins Scientific
  • PPD
  • ICON Plc
  • Pharmaron
  • Inotiv
  • ChemPartner
  • JOINN Lab
  • EVOTEC
  • Medicilon
  • Crown Bioscience
  • Champion Oncology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Biomedical CRO Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Preclinical CRO
  5. 1.2.3 Clinical CRO
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Biomedical CRO Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Biological Industry
  9. 1.3.3 Medical Industry
  10. 1.4 Global Market Growth Prospects
  11. 1.5 Global Biomedical CRO Growth Trends by Region
  12. 1.5.1 Global Biomedical CRO Market Size by Region: 2021 VS 2025 VS 2032
  13. 1.5.2 Biomedical CRO Market Size by Region (2021-2026)
  14. 1.5.3 Biomedical CRO Market Size by Region (2027-2032)
  15. 1.6 Assumptions and Limitations
  16. 1.7 Study Goals and Objectives
  17. 1.8 Years Considered
2 Global Biomedical CRO Market Dynamics
  1. 2.1 Biomedical CRO Industry Trends
  2. 2.2 Biomedical CRO Industry Drivers
  3. 2.3 Biomedical CRO Industry Opportunities and Challenges
  4. 2.4 Biomedical CRO Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Biomedical CRO Revenue by Company (2021-2026)
  2. 3.2 Global Biomedical CRO Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Biomedical CRO Key Company Head office and Area Served
  4. 3.4 Global Biomedical CRO Company, Product Type & Application
  5. 3.5 Global Biomedical CRO Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Biomedical CRO Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Biomedical CRO Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Biomedical CRO Tier 1, Tier 2, and Tier 3
4 Biomedical CRO Market by Type
  1. 4.1 Global Biomedical CRO Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Biomedical CRO Market Size by Type (2021-2032)
  3. 4.3 Global Biomedical CRO Market Size Share by Type (2021-2032)
5 Biomedical CRO Market by Application
  1. 5.1 Global Biomedical CRO Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Biomedical CRO Market Size by Application (2021-2032)
  3. 5.3 Global Biomedical CRO Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Charles River
  2. 6.1.1 Charles River Company Information
  3. 6.1.2 Charles River Business Overview
  4. 6.1.3 Charles River Biomedical CRO Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Charles River Biomedical CRO Product Portfolio
  6. 6.1.5 Charles River Recent Developments
  7. 6.2 Wuxi AppTec
  8. 6.2.1 Wuxi AppTec Company Information
  9. 6.2.2 Wuxi AppTec Business Overview
  10. 6.2.3 Wuxi AppTec Biomedical CRO Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Wuxi AppTec Biomedical CRO Product Portfolio
  12. 6.2.5 Wuxi AppTec Recent Developments
  13. 6.3 Labcorp
  14. 6.3.1 Labcorp Company Information
  15. 6.3.2 Labcorp Business Overview
  16. 6.3.3 Labcorp Biomedical CRO Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Labcorp Biomedical CRO Product Portfolio
  18. 6.3.5 Labcorp Recent Developments
  19. 6.4 Eurofins Scientific
  20. 6.4.1 Eurofins Scientific Company Information
  21. 6.4.2 Eurofins Scientific Business Overview
  22. 6.4.3 Eurofins Scientific Biomedical CRO Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Eurofins Scientific Biomedical CRO Product Portfolio
  24. 6.4.5 Eurofins Scientific Recent Developments
  25. 6.5 PPD
  26. 6.5.1 PPD Company Information
  27. 6.5.2 PPD Business Overview
  28. 6.5.3 PPD Biomedical CRO Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 PPD Biomedical CRO Product Portfolio
  30. 6.5.5 PPD Recent Developments
  31. 6.6 ICON Plc
  32. 6.6.1 ICON Plc Company Information
  33. 6.6.2 ICON Plc Business Overview
  34. 6.6.3 ICON Plc Biomedical CRO Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 ICON Plc Biomedical CRO Product Portfolio
  36. 6.6.5 ICON Plc Recent Developments
  37. 6.7 Pharmaron
  38. 6.7.1 Pharmaron Company Information
  39. 6.7.2 Pharmaron Business Overview
  40. 6.7.3 Pharmaron Biomedical CRO Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Pharmaron Biomedical CRO Product Portfolio
  42. 6.7.5 Pharmaron Recent Developments
  43. 6.8 Inotiv
  44. 6.8.1 Inotiv Company Information
  45. 6.8.2 Inotiv Business Overview
  46. 6.8.3 Inotiv Biomedical CRO Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Inotiv Biomedical CRO Product Portfolio
  48. 6.8.5 Inotiv Recent Developments
  49. 6.9 ChemPartner
  50. 6.9.1 ChemPartner Company Information
  51. 6.9.2 ChemPartner Business Overview
  52. 6.9.3 ChemPartner Biomedical CRO Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 ChemPartner Biomedical CRO Product Portfolio
  54. 6.9.5 ChemPartner Recent Developments
  55. 6.10 JOINN Lab
  56. 6.10.1 JOINN Lab Company Information
  57. 6.10.2 JOINN Lab Business Overview
  58. 6.10.3 JOINN Lab Biomedical CRO Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 JOINN Lab Biomedical CRO Product Portfolio
  60. 6.10.5 JOINN Lab Recent Developments
  61. 6.11 EVOTEC
  62. 6.11.1 EVOTEC Company Information
  63. 6.11.2 EVOTEC Business Overview
  64. 6.11.3 EVOTEC Biomedical CRO Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 EVOTEC Biomedical CRO Product Portfolio
  66. 6.11.5 EVOTEC Recent Developments
  67. 6.12 Medicilon
  68. 6.12.1 Medicilon Company Information
  69. 6.12.2 Medicilon Business Overview
  70. 6.12.3 Medicilon Biomedical CRO Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Medicilon Biomedical CRO Product Portfolio
  72. 6.12.5 Medicilon Recent Developments
  73. 6.13 Crown Bioscience
  74. 6.13.1 Crown Bioscience Company Information
  75. 6.13.2 Crown Bioscience Business Overview
  76. 6.13.3 Crown Bioscience Biomedical CRO Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Crown Bioscience Biomedical CRO Product Portfolio
  78. 6.13.5 Crown Bioscience Recent Developments
  79. 6.14 Champion Oncology
  80. 6.14.1 Champion Oncology Company Information
  81. 6.14.2 Champion Oncology Business Overview
  82. 6.14.3 Champion Oncology Biomedical CRO Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Champion Oncology Biomedical CRO Product Portfolio
  84. 6.14.5 Champion Oncology Recent Developments
7 North America
  1. 7.1 North America Biomedical CRO Market Size (2021-2032)
  2. 7.2 North America Biomedical CRO Market Size by Type
  3. 7.2.1 North America Biomedical CRO Market Size by Type (2021-2026)
  4. 7.2.2 North America Biomedical CRO Market Size by Type (2027-2032)
  5. 7.2.3 North America Biomedical CRO Market Share by Type (2021-2032)
  6. 7.3 North America Biomedical CRO Market Size by Application
  7. 7.3.1 North America Biomedical CRO Market Size by Application (2021-2026)
  8. 7.3.2 North America Biomedical CRO Market Size by Application (2027-2032)
  9. 7.3.3 North America Biomedical CRO Market Share by Application (2021-2032)
  10. 7.4 North America Biomedical CRO Market Size by Country
  11. 7.4.1 North America Biomedical CRO Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Biomedical CRO Market Size by Country (2021-2026)
  13. 7.4.3 North America Biomedical CRO Market Size by Country (2027-2032)
  14. 7.4.4 North America Biomedical CRO Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Biomedical CRO Market Size (2021-2032)
  2. 8.2 Europe Biomedical CRO Market Size by Type
  3. 8.2.1 Europe Biomedical CRO Market Size by Type (2021-2026)
  4. 8.2.2 Europe Biomedical CRO Market Size by Type (2027-2032)
  5. 8.2.3 Europe Biomedical CRO Market Share by Type (2021-2032)
  6. 8.3 Europe Biomedical CRO Market Size by Application
  7. 8.3.1 Europe Biomedical CRO Market Size by Application (2021-2026)
  8. 8.3.2 Europe Biomedical CRO Market Size by Application (2027-2032)
  9. 8.3.3 Europe Biomedical CRO Market Share by Application (2021-2032)
  10. 8.4 Europe Biomedical CRO Market Size by Country
  11. 8.4.1 Europe Biomedical CRO Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Biomedical CRO Market Size by Country (2021-2026)
  13. 8.4.3 Europe Biomedical CRO Market Size by Country (2027-2032)
  14. 8.4.4 Europe Biomedical CRO Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Biomedical CRO Market Size (2021-2032)
  2. 9.2 China Biomedical CRO Market Size by Type
  3. 9.2.1 China Biomedical CRO Market Size by Type (2021-2026)
  4. 9.2.2 China Biomedical CRO Market Size by Type (2027-2032)
  5. 9.2.3 China Biomedical CRO Market Share by Type (2021-2032)
  6. 9.3 China Biomedical CRO Market Size by Application
  7. 9.3.1 China Biomedical CRO Market Size by Application (2021-2026)
  8. 9.3.2 China Biomedical CRO Market Size by Application (2027-2032)
  9. 9.3.3 China Biomedical CRO Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Biomedical CRO Market Size (2021-2032)
  2. 10.2 Asia Biomedical CRO Market Size by Type
  3. 10.2.1 Asia Biomedical CRO Market Size by Type (2021-2026)
  4. 10.2.2 Asia Biomedical CRO Market Size by Type (2027-2032)
  5. 10.2.3 Asia Biomedical CRO Market Share by Type (2021-2032)
  6. 10.3 Asia Biomedical CRO Market Size by Application
  7. 10.3.1 Asia Biomedical CRO Market Size by Application (2021-2026)
  8. 10.3.2 Asia Biomedical CRO Market Size by Application (2027-2032)
  9. 10.3.3 Asia Biomedical CRO Market Share by Application (2021-2032)
  10. 10.4 Asia Biomedical CRO Market Size by Country
  11. 10.4.1 Asia Biomedical CRO Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Biomedical CRO Market Size by Country (2021-2026)
  13. 10.4.3 Asia Biomedical CRO Market Size by Country (2027-2032)
  14. 10.4.4 Asia Biomedical CRO Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Biomedical CRO Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Biomedical CRO Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Biomedical CRO Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Biomedical CRO Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Biomedical CRO Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Biomedical CRO Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Biomedical CRO Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Biomedical CRO Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Biomedical CRO Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Biomedical CRO Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Biomedical CRO Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Biomedical CRO Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Biomedical CRO Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Biomedical CRO Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research